Southland Equity Partners LLC Pfizer Inc Transaction History

Southland Equity Partners LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$32.09 - $37.51 $10,172 - $11,890	317 Added 4.56%	7,262 $241 Million
Q2 2023 Jan 02, 2024	BUY	$36.12 - $41.79 $3,792 - $4,387	105 Added 1.54%	6,945 $255 Million
Q1 2023 Jan 02, 2024	BUY	$39.39 - $51.28 $7,326 - $9,538	186 Added 2.8%	6,840 $279 Million
Q4 2022 Jan 02, 2024	SELL	$41.75 - $54.5 $15,948 - $20,819	-382 Reduced 5.43%	6,654 $341 Million
Q3 2022 Jan 02, 2024	BUY	$43.76 - $53.42 $350 - $427	8 Added 0.11%	7,036 $308 Million
Q2 2022 Jan 02, 2024	SELL	$46.53 - $55.17 $3,815 - $4,523	-82 Reduced 1.15%	7,028 $368 Million
Q1 2022 Jan 02, 2024	BUY	$45.75 - $56.69 $9,424 - $11,678	206 Added 2.98%	7,110 $368 Million
Q4 2021 Jan 02, 2024	BUY	$41.32 - $61.25 $867 - $1,286	21 Added 0.31%	6,904 $408 Million
Q3 2021 Jan 02, 2024	BUY	$39.25 - $50.42 $9,498 - $12,201	242 Added 3.64%	6,883 $296 Million
Q2 2021 Jan 02, 2024	SELL	$35.91 - $40.68 $35,766 - $40,517	-996 Reduced 13.04%	6,641 $260 Million
Q1 2021 Jan 02, 2024	BUY	$33.49 - $37.77 $12,357 - $13,937	369 Added 5.08%	7,637 $277 Million
Q4 2020 Jan 02, 2024	BUY	$33.47 - $42.56 $243,259 - $309,326	7,268 New	7,268 $268 Million

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Southland Equity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Southland Equity Partners LLC with notifications on news.